|
|
Gene Symbol |
CR1 |
|
Aliases |
C3BR, C4BR, CD35, KN |
|
Entrez Gene ID |
|
|
Gene Name |
Complement C3b/C4b receptor 1 (Knops blood group) |
|
Chromosomal Location |
1q32.2 |
|
HGNC ID |
|
|
Summary |
This gene is a member of the receptors of complement activation (RCA) family and is located in the 'cluster RCA' region of chromosome 1. The gene encodes a monomeric single-pass type I membrane glycoprotein found on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Decreases in expression of this protein and/or mutations in its gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus and sarcoidosis. Mutations in this gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. Alternate allele-specific splice variants, encoding different isoforms, have been characterized. Additional allele specific isoforms, including a secreted form, have been described but have not been fully characterized. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Complement receptor type 1, C3-binding protein, C3b/C4b receptor, CD35 antigen, Knops blood group antigen, complement component (3b/4b) receptor 1 (Knops blood group), complement receptor 1 |
|
Function |
Membrane immune adherence receptor that plays a critical role in the capture and clearance of complement-opsonized pathogens by erythrocytes and monocytes/macrophages (PubMed:2963069). Mediates the binding by these cells of particles and immune complexes that have activated complement to eliminate them from the circulation (PubMed:2963069). Acts also in the inhibition of spontaneous complement activation by impairing the formation and function of the alternative and classical pathway C3/C5 convertases, and by serving as a cofactor for the cleavage by factor I of C3b to iC3b, C3c and C3d,g, and of C4b to C4c and C4d (PubMed:2972794, PubMed:8175757). Plays also a role in immune regulation by contributing, upon ligand binding, to the generation of regulatory T cells from activated helper T cells. (Microbial infection) Acts as a receptor for Epstein-Barr virus |
|
|
|
|
|
UniProt |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00084 |
Sushi |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000356016 |
|
P17927 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Myelofibrosis |
|
Anemia |
|
Hematologic Disease |
|
Neutropenia |
|
Myelodysplastic Syndrome |
|
Cardiovascular Diseases |
Atherosclerosis |
|
Deep Vein Thrombosis |
|
Pulmonary Hypertension |
|
Myocardial Infarction |
|
Coronary heart disease |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Thalassemia |
|
Hemorrhages |
|
Digestive System Diseases |
Liver Diseases |
|
Endocrine System Diseases |
PCOS |
|
Immune System Diseases |
Graft-vs-Host Disease |
|
Inflammatory Skin And Bowel Disease |
|
Rheumatoid Arthritis |
|
Musculoskeletal Diseases |
Spondylitis |
|
Arthritis |
|
Necrosis |
|
Neoplasms |
Myeloid Leukemia |
30341082, 29386195, 29321554, 30009981, 30926091, 29597002, 27916512, 29981272, 29991495, 26168067, 29950211, 29946906, 27434660, 25704584, 30058714, 29214689, 30342553, 31221952, 27930388, 29644709, 30122012, 30456896, 29289481, 30355812, 29051022, 31309713, 31148220, 29243031, 306 |
Lymphoma |
30694529, 28369839, 30953029, 26796979, 29434288, 30122016, 25652691, 27587245, 27012928, 30008598, 28533060, 26134007, 27018207 |
Leukemia |
28971501, 26901709, 29694642, 30742559, 27856368, 28558762, 29348129, 27935576, 26662400, 29275139, 29702054, 30419861, 27695097, 28215040, 29577208, 26903380, 27044907, 26996140, 29907809, 27088379, 27000734, 29469924, 27712033, 29330392, 25865650, 27002921, 28971504, 27587244, 284 |
Adenocarcinoma Of Pancreas |
|
Neoplasms |
|
Ovarian Cancer |
|
Hematologic Neoplasms |
|
Multiple Myeloma |
|
Lung Cancer |
|
Rhabdomyoma |
|
Genital Neoplasms, Male |
|
Embryonal carcinoma |
|
Nervous System Diseases |
Systemic Lupus Erythematosus |
|
Nutritional and Metabolic Diseases |
Haemoglobinuria |
|
Psychiatric/Brain disorders |
Alzheimer and Parkinson Diseases |
|
Psychosis |
|
Renal Disorder |
Glomerulopathy |
|
Alport Syndrome |
|
Reproductive disorders |
Endometrioma |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
PCOS, Inflammation |
|
Rotterdam Criteria |
Direct
|
8 PCOS Subjects and 8 Controls |
We conducted the peripheral-blood transcriptome in PCOS using microarray and identified dysregulated genes involved in inflammatory response. Our data strongly supported the notion that systemic rather than a local inflammatory response is implicated in the etiology of PCOS. |
|
|
|
|